AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
APIXABAN TABLETS 2.5 MG
7 registrations across 3 African markets— 7 active
Markets with APIXABAN TABLETS 2.5 MG
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| XABAN 2.5MG TABLETS Film Coated Tablets | 🇿🇲Zambia | Dawa Limited | active | Jun 2031 |
| APILTOX 2.5 Tablet, Filmcoated | 🇿🇲Zambia | BioMatrix Healthcare Private Limited | active | Apr 2031 |
| Apigy 2.5 Tablets+ Filmcoated | 🇿🇲Zambia | Cipla Ltd | active | Apr 2031 |
| Axaban-Denk 2.5 mg Film Coated Tablets | 🇿🇲Zambia | Denk Pharma GmbH & Co. KG | active | Mar 2031 |
| Supixa 2.5 Film Coated Tablets | 🇿🇲Zambia | MICRO LABS LTD | active | Nov 2030 |
| APIZABAN Coated Tablet | 🇰🇪Kenya | AVETINA LIFE SCIENCES LTD | active | Mar 2028 |
| APIQX 2.5 Tablets | 🇹🇿Tanzania | Hetero Labs Limited | active | — |
APIXABAN TABLETS 2.5 MG in Africa — Regulatory Overview
APIXABAN TABLETS 2.5 MG is registered across 3 African markets with 7 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Zambia, Kenya, Tanzania. AfricaRegulatory refreshes this data daily from official government sources.
Of the 7 registrations, 7 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.